BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
09 août 2021 11h58 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
Verano to Open 32nd MÜV™ Florida Medical Cannabis Dispensary in Historic St. Augustine
23 avr. 2021 07h00 HE
|
Verano Holdings Corp.
Verano secures the fourth largest retail footprint in Florida. St. Augustine is the fifth MÜV™ location with a drive-through to offer patients a convenient method of order pickup. CHICAGO,...
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
04 avr. 2019 09h15 HE
|
Adhera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, NC, April 04, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and...
INmune Bio Awarded a $1 Million Grant for the Development of XPro1595 for the treatment of Alzheimer’s Disease
11 févr. 2019 08h00 HE
|
INmune Bio, Inc.
The Alzheimer’s Association awarded INmune Bio the Part the Cloud to RESCUE grant to target neuroinflammation in Alzheimer’s Disease LA JOLLA, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- INmune...
Endonovo Expands SofPulse Commercialization
13 déc. 2018 09h20 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
IMAC Holdings, Inc. Announces Research Scientist, Dr. Ian White, Joins IMAC Regeneration Centers As Chief Scientific Officer
13 sept. 2018 15h16 HE
|
IMAC Holdings, Inc.
Brentwood, TN, Sept. 13, 2018 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC”), a provider of regenerative rehabilitation orthopedic medical treatments without the use of surgery or opioids,...
Emerging Science Shaping Behavioral Health Service Delivery:The Focus of October mhca National Innovation Incubator
11 oct. 2017 07h30 HE
|
Open Minds
Gettysburg, PA, Oct. 11, 2017 (GLOBE NEWSWIRE) -- mhca will kick off their Fall conference of 2017 at the Westin Kierland Resort in Scottsdale, Arizona. The conference will kick off with a half-day...
Cantabio Pharmaceuticals Announces the Development of Small Molecule Chaperones of the Abeta Peptide for the Treatment of Alzheimer's Disease in Collaboration with NovAliX
12 avr. 2016 12h00 HE
|
Cantabio Pharmaceuticals Inc.
PALO ALTO, Calif., April 12, 2016 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals Inc. (OTCQB:CTBO) announced today a new preclinical therapeutic program for Alzheimer’s Disease which it is...
CANTABio and Gardedam Therapeutics complete Merger to Tackle Development of Novel Therapeutics for Alzheimer's and Parkinson's Disease
21 déc. 2015 13h00 HE
|
Cantabio Pharmaceuticals Inc.
PALO ALTO, Calif., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals, Inc. ("Cantabio") (OTCQB:CTBO) is pleased to announce the completion of its reverse merger (the "Merger") with...
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26
25 juin 2014 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, June 25, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), will present a corporate update on their Advanced Therapies for the Human...